Your browser doesn't support javascript.
loading
Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review.
Wang, Wei-Ting; Wu, Tsung-Hui; Er, Leay-Kiaw; Huang, Chien-Wei; Tu, Kun-Hua; Fan, Kang-Chih; Tsai, Cheng-Hsuan; Wang, Shu-Yi; Wu, Chun-Yi; Huang, Shu-Heng; Liu, Han-Wen; Tseng, Fen-Yu; Wu, Wan-Chen; Chang, Chin-Chen; Cheng, Hao-Min; Lin, Liang-Yu; Chueh, Jeff S; Lin, Yen-Hung; Hwu, Chii-Min; Wu, Vin-Cent.
Afiliación
  • Wang WT; Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
  • Wu TH; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
  • Er LK; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
  • Huang CW; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
  • Tu KH; Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
  • Fan KC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, Hualien, Taiwan, ROC.
  • Tsai CH; School of Medicine, Tzu-Chi University College of Medicine, Hualien, Taiwan, ROC.
  • Wang SY; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
  • Wu CY; Division of Nephrology, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC.
  • Huang SH; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
  • Liu HW; Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, ROC.
  • Tseng FY; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan, ROC.
  • Wu WC; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC.
  • Chang CC; Division of Cardiology, Department of Internal Medicine and Cardiovascular Center, National Taiwan University Hospital, Taipei, Taiwan, ROC.
  • Cheng HM; Division of Endocrinology & Metabolism, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan, ROC.
  • Lin LY; Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, ROC.
  • Chueh JS; Division of Endocrinology & Metabolism, Department of Internal Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan, ROC.
  • Lin YH; Division of Endocrinology & Metabolism, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, ROC.
  • Hwu CM; Division of Endocrinology & Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROC.
  • Wu VC; Division of Endocrinology & Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROC.
Hypertens Res ; 47(5): 1103-1119, 2024 May.
Article en En | MEDLINE | ID: mdl-38228750
ABSTRACT
This comprehensive review offers a thorough exploration of recent advancements in our understanding of the intricate cardiovascular complications associated with Primary Aldosteronism (PA). PA encompasses a spectrum of conditions characterized by hypertension and excessive production of aldosterone operating independently of the renin-angiotensin system. Given its association with an elevated risk of cardiovascular and cerebrovascular complications, as well as a higher incidence of metabolic syndrome in comparison to individuals with essential hypertension (EH), an accurate diagnosis of PA is of paramount importance. This review delves into the intricate interplay between PA and cardiovascular health and focuses on the key pathophysiological mechanisms contributing to adverse cardiac outcomes. The impact of different treatment modalities on cardiovascular health is also examined, offering insights into potential therapeutic approaches. By highlighting the significance of recognizing PA as a significant contributor to cardiovascular morbidity, this review emphasizes the need for improved screening, early diagnosis, and tailored management strategies to both enhance patient care and mitigate the burden of cardiovascular diseases. The findings presented herein underscore the growing importance of PA in the context of cardiovascular medicine and emphasize the potential for translating these insights into targeted interventions to improve patient outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Hiperaldosteronismo Tipo de estudio: Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Hypertens Res Asunto de la revista: ANGIOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Hiperaldosteronismo Tipo de estudio: Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Hypertens Res Asunto de la revista: ANGIOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido